IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,970,700 | -60.4% | 5,000,000 | -60.0% | 0.03% | -58.1% |
| Q2 2023 | $12,538,375 | -0.1% | 12,500,000 | 0.0% | 0.06% | +1.6% |
| Q1 2023 | $12,551,625 | +54.5% | 12,500,000 | +66.7% | 0.06% | +60.5% |
| Q4 2022 | $8,121,900 | +7.7% | 7,500,000 | 0.0% | 0.04% | +11.8% |
| Q3 2022 | $7,542,000 | -4.7% | 7,500,000 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $7,910,000 | -7.9% | 7,500,000 | 0.0% | 0.03% | +6.2% |
| Q1 2022 | $8,584,000 | +2.6% | 7,500,000 | 0.0% | 0.03% | +3.2% |
| Q4 2021 | $8,370,000 | -6.1% | 7,500,000 | 0.0% | 0.03% | -20.5% |
| Q3 2021 | $8,910,000 | +0.5% | 7,500,000 | 0.0% | 0.04% | -4.9% |
| Q2 2021 | $8,868,000 | +6.7% | 7,500,000 | 0.0% | 0.04% | -8.9% |
| Q1 2021 | $8,314,000 | -0.8% | 7,500,000 | 0.0% | 0.04% | -8.2% |
| Q4 2020 | $8,385,000 | +12.9% | 7,500,000 | 0.0% | 0.05% | +2.1% |
| Q3 2020 | $7,424,000 | – | 7,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 5,300,000 | $6,265,000 | 0.59% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,457,000 | $5,272,000 | 0.40% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,416,000 | $12,314,000 | 0.28% |
| AQR Arbitrage LLC | 7,700,000 | $9,119,000 | 0.26% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,227,000 | $25,018,000 | 0.22% |
| LINDEN ADVISORS LP | 26,849,000 | $31,752,000 | 0.19% |
| HBK INVESTMENTS L P | 10,000,000 | $11,822,000 | 0.05% |
| Calamos Advisors LLC | 7,500,000 | $8,910,000 | 0.04% |
| Jefferies Group LLC | 3,245,000 | $3,856,677 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,700,000 | $11,487,000 | 0.02% |